Fallypride

From WikiMD's WELLNESSPEDIA

Fallypride is a radiotracer that is used in positron emission tomography (PET) imaging. It is a high-affinity dopamine D2/D3 receptor antagonist, which allows it to be used in the study of diseases such as schizophrenia and Parkinson's disease, which are characterized by alterations in dopamine function.

Chemistry[edit]

Fallypride is a fluorine-18 labeled compound. It is a derivative of sulpiride, a D2/D3 receptor antagonist. The fluorine-18 label allows it to be detected by PET imaging.

Pharmacology[edit]

Fallypride binds to D2 and D3 receptors with high affinity, which allows it to be used as a radiotracer in PET imaging. It has a high selectivity for these receptors, which means it can provide a clear image of their distribution in the brain.

Clinical use[edit]

Fallypride is used in PET imaging to study the distribution and density of D2/D3 receptors in the brain. This can be useful in the study of diseases such as schizophrenia and Parkinson's disease, which are characterized by alterations in dopamine function. It can also be used to study the effects of drugs on these receptors.

Research[edit]

Research has shown that fallypride can be used to image D2/D3 receptors in the human brain with high resolution. This has made it a valuable tool in the study of diseases that affect dopamine function.

See also[edit]


Stub icon

This WikiMD article can only be edited by registered and verified editors. You can log in or register.


  • Fallypride
    Fallypride

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Fallypride&oldid=6493620"